Sorafenib combination with imatinib enhances apoptotic and cell cycle arrest effects with no effect on viability and BCR-ABL expression of K-562 cells.
| Autor: | Al-Husein, Belal A., Al-Azayzih, Ahmad, Redha, Fatema S. |
|---|---|
| Zdroj: | Journal of Applied Pharmaceutical Science; Oct2024, Vol. 14 Issue 10, p190-195, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|